ResApp Health Limited Stocks

ResApp Health Limited develops digital healthcare solutions to assist doctors and allow patients to diagnose and manage respiratory disease. The company offers ResAppDx, a smartphone-based acute respiratory disease diagnostic test; and SleepCheckRx, a smartphone application for at-home sleep apnoea screening. Its technology uses mathematical features for the diagnosis of pneumonia, asthma, and chronic obstructive pulmonary disease. The company was formerly known as Narhex Life Sciences Limited. ResApp Health Limited was incorporated in 2000 and is headquartered in Brisbane, Australia. As of September 15, 2022, ResApp Health Limited operates as a subsidiary of Pfizer Australia Holdings Pty Limited.